Fig. 1From: Evidence that tirzepatide protects against diabetes-related cardiac damagesMeta-analysis of Cardiovascular Safety of Tirzepatide in Randomized Clinical Trials (2020–2023) The forest plot of the meta-analysis was created using Stata software (version 16.0, Stata Corp., College Station, TX)Back to article page